Tea plant root extract (TRE) as an antineoplastic agent.
The antitumour effect of tea plant root extract (TRE) has been evaluated against Ehrlich ascites carcinoma (EAC) in Balb-C mice. Significant increases of survival times of the TRE-treated, tumour-bearing mice have been confirmed repeatedly with respect to the control group. TRE inhibited the tumour cell growth and reversed the changes of haematological parameters consequent to tumour inoculation.
Sur
P
P
Division of Pharmacology & Experimental Therapeutics, Indian Institute of Chemical Biology, Calcutta.
Ganguly
D K
DK
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000633:toxicity; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D005472:Fluorouracil; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D013662:Tea / Q000737:chemistry*; D014407:Tumor Cells, Cultured
D000972:Antineoplastic Agents, Phytogenic; D013662:Tea; D005472:Fluorouracil